Correlation Between Akebia Therapeutics and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akebia Therapeutics and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akebia Therapeutics and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akebia Therapeutics and Immunoprecise Antibodies, you can compare the effects of market volatilities on Akebia Therapeutics and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akebia Therapeutics with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akebia Therapeutics and Immunoprecise Antibodies.

Diversification Opportunities for Akebia Therapeutics and Immunoprecise Antibodies

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Akebia and Immunoprecise is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Akebia Therapeutics and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Akebia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akebia Therapeutics are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Akebia Therapeutics i.e., Akebia Therapeutics and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Akebia Therapeutics and Immunoprecise Antibodies

Given the investment horizon of 90 days Akebia Therapeutics is expected to generate 1.56 times more return on investment than Immunoprecise Antibodies. However, Akebia Therapeutics is 1.56 times more volatile than Immunoprecise Antibodies. It trades about 0.03 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.36 per unit of risk. If you would invest  37.00  in Akebia Therapeutics on March 29, 2022 and sell it today you would earn a total of  0.00  from holding Akebia Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Akebia Therapeutics  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
Akebia Therapeutics 
Akebia Performance
0 of 100
Over the last 90 days Akebia Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in July 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Akebia Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Immunoprecise Antibodies is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Structure and Payout Changes

Last Split Factor
1:5
Dividend Date
2020-11-23
Last Split Date
2020-11-23

Immunoprecise Price Channel

Akebia Therapeutics and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Akebia Therapeutics and Immunoprecise Antibodies

The main advantage of trading using opposite Akebia Therapeutics and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akebia Therapeutics position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.

Akebia Therapeutics

Pair trading matchups for Akebia Therapeutics

Northrop Grumman vs. Akebia Therapeutics
Cincinnati Financial vs. Akebia Therapeutics
Chevron Corp vs. Akebia Therapeutics
Teucrium Corn vs. Akebia Therapeutics
Merck vs. Akebia Therapeutics
Conagra Brands vs. Akebia Therapeutics
Micron Technology vs. Akebia Therapeutics
Home Depot vs. Akebia Therapeutics
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Akebia Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Akebia Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Akebia Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Akebia Therapeutics.
The idea behind Akebia Therapeutics and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Micron Technology vs. Immunoprecise Antibodies
Macroaxis vs. Immunoprecise Antibodies
Merck vs. Immunoprecise Antibodies
Conagra Brands vs. Immunoprecise Antibodies
Cincinnati Financial vs. Immunoprecise Antibodies
Verizon Communications vs. Immunoprecise Antibodies
Northrop Grumman vs. Immunoprecise Antibodies
Teucrium Corn vs. Immunoprecise Antibodies
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Immunoprecise Antibodies as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Immunoprecise Antibodies' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Immunoprecise Antibodies' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Immunoprecise Antibodies.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go